Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2017

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2017

Enanta Pharma (ENTA) Tops Q2 EPS by 10c

May 8, 2017 4:02 PM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of ($0.28), $0.10 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $8.96 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More